Agios Pharmaceuticals | Валовая Прибыль



Gross Profit On Sales Изменить Дата
AbbVie USD 10.71B 458M 2024-12
Agios Pharmaceuticals USD 9.47M 1.29M 2024-12
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Amgen USD 5.97B 781M 2024-12
Arrowhead Research -173085000 2.55M 2024-12
Astellas Pharma JPY 382.44B 36.45B 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 6.01B 1.13B 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Daiichi Sankyo JPY 424.35B 67.89B 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Exelixis USD 546.79M 24.58M 2025-01
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Incyte USD 985.09M 111.22M 2025-03
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Merck USD 12.77B 849M 2025-03
Moderna USD 17M 403M 2025-03
Novartis USD 10.23B 294M 2024-12
Novartis USD 10.24B 313M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Agios Pharmaceuticals Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.